Nestle wins EU conditional approval to buy Novartis nutrition business
The world's biggest food and beverage company Nestle won conditional approval from the European Union on Friday to buy the nutrition business of pharmaceutical giant Novartis.
The European Commission, the EU antitrust watchdog, said the proposed transaction could significantly impede competition in the markets for healthcare nutrition delivered to patients via tubes in France and Spain. In France, the transaction would bring together two of the main suppliers and create a clear market leader, while in Spain it would strengthen the current leading position of Novartis, it found.
After Nestle agreed to sell the entire healthcare nutrition business of Novartis in France and its own healthcare nutrition business in Spain, the Commission concluded that they would be sufficient to address the competition concerns. Nestle and Novartis are both Swiss companies. The deal, which was worth €1.9 billion (about $2.5 billion), could make Nestle the second-largest player in the field. (english.people.com.cn)
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.